Increased numbers of mast cells in human middle ear cholesteatomas: Implications for treatment

American Journal of Otology

Volumn 19, Issue 3, 1998, Pages 266-272

  Albino, Anthony P ^a   Reed, Jon A ^a   Bogdany, Jennifer K ^b   Sassoon, Jodi ^a   Parisier, Simon C ^a  

^a EAR AND THROAT HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cholesteatoma; Keratinocyte; Mast cell

Indexed keywords

ARTICLE; CELL DENSITY; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EARDRUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAST CELL; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM;

CHOLESTEATOMA; CONNECTIVE TISSUE; HUMANS; KERATINOCYTES; MAST CELLS; TYMPANIC MEMBRANE;

EID: 0031980337     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Pansier SC. Management of cholesteatoma. Otolaryngol Clin North Am 1989;22:927W.
2. Watt FM, Kubler M-D, Hotchin NA, et al. Regulation of keratinocyte terminal differentiation by integrin-extracellular matrix interactions. J Cell Sci 1993;106:175-82.
3. Waldorf H, Fewkes J. Wound healing [Review]. Adv Dennatol 1995;10:77-96; Discussion, 97.
4. Barbul A, Regan MC. Immune involvement in wound healing. [Review]. Otolaryngol Clin North Am 1995;28:955-68.
5. Horn DB. Growth factors in wound healing [Review]. Otolaryngol Clin North Am 1995:28:933-53.
6. Harvima IT, Horsmanheimo L, Naukkarinen A, et al. Mast cell proteinases and cytokines in skin inflammation [Review]. Arch DermatolRes 1994;287:61-7.
7. Galli SJ. Biology of disease: new insights into the riddle of the mast cell: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
8. Church MK, Okayama Y, Bradding P. The role of the mast cell in acute and chronic allergic inflammation [Review]. Ann N YAcad Sci 1994:725:13-21.
9. Malaviya R, Ikeda T, Ross E, et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha [see comments]. Nature 1996;381:77-80.
10. Dabbous MK, North SM, Haney L, et al. Effects of mast cellmacrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis 1995:13:33-41.
11. Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of 1L-8 production and intercellular adhesion molecule-1 expression. J limmmol 1996; 156:275-83.
12. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mastcell migration. Blood 1995;86:2488-93.
13. Hebda PA, Collins MA, Tharp MD. Mast cell and myofibroblast in wound healing [Review]. Dennatol Clin 1993;ll:685-96.
14. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growih factor. Lab Invest 1995 ;72:215-22.
15. Galli SJ. New concepts about the mast cell [Review]. N Engl J Med 1993:328:257-65.
16. Cowen T, Trigg P, Eady RA. Distribution of mast cells in human dermis: development of a mapping technique. Br J Dennatol 1979; 100: 635-41.
17. Michaels L. Biology of cholesteatoma [Review]. Otolaryngol Clin North Am 1989;22:869-81.
18. Robinson AC, Hawke M. The motility of keratinocytes in cholesteatoma: an ultrastructural approach to epithelial migration. J Otolaryngol 1991;20:353-9.
19. Youngs R, Rowles P. The spatial organisation of keratinocytes in acquired middle ear cholesteatoma resembles that of external auditory canal skin and pars flaccida. Acta Otolaryngol 1990;! 10: 115-9.
20. Widemar L, Bloom GD, Hellstrom S, et al. Mast cells in the pars flaccida of the tympanic membrane. Acta Otolaryngol (Stockh) 1984;(Suppl)414:115-7.
21. Hochstrasser K, Albrecht GJ, Gebhard W, et al. Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma. Ear Arch Otorhinolaryngol 1994;251:30-5.
22. Galli SJ, Gordon JR, Wershil BK. Mast cell cytokines in allergy and inflammation [Review]. Agents Actions Sitppl 1993;43: 209-20.
23. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics 1982;70:48-53.
24. Shea CR, Prieto VG. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cutan Pathol 1994;21:247-5I.
25. Mekori YA, Oh CK, Metcalfe DD. The role of c-Kit and its ligand, stem cell factor, in mast cell apoptosis [Review]. IntArch Allergy Immunol 1995;107:136-8.
26. Reed JA, McNutt NS, Bogdany JK, et al. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. / Cutan Pathol 1996;23: 495-505.
27. Mamey SR, Jr. Mast cell disease [Review]. Allergy Proc 1992;13: 303-10.
28. Schilling V, Bujia J, Negri B, et al. Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 1991:12:249-53.
29. Iino Y, Toriyama M, Ogawa H, et al. Cholesteatoma debris as an activator of human monocytes. Potentiation of the production of tumor necrosis factor. Acta Otolaryngol 1990:110:410-5.
30. Iino Y, Toriyama M, Ohmi S, et al. Activation of peritoneal macrophages with human cholesteatoma debris and alpha-keratin. Acta Otolaryngol 1990; 109:444-9.
31. Palva T, Taskinen E. Inflammatory cells in chronic middle ear disease. Value of lymphocyte subset determination in ear surgery. Acta Ololaryngol 1990; 109:124-9.
32. Stammberger M, Holly A, Bujia J. [Immunohistochemical studies of vascularization of cholesteatoma]. [German]. Laryngorhinootologie 1993;72:170-3.
33. Desloge RB, Carew JF, Finstad CL, et al. DMA analysis of human cholesteatomas. Am J Otol 1997; 18:155-59.
34. Desloge RB, Finstad CL, Han JC, et al. Altered regulation of cell surface peptidases in human cholesteatomas. Otolaryngol Head Neck SH/S 1997;116:58-63.
35. Bolton LL, Montagna W. Mast cells in human ulcers. Am J Dermatopathol (Abstract) 1993;15:133-8.
36. Widemar L, Hellstrom S, Stentors LE, et al. An overlooked site of tissue mast cells - the human tympanic membrane - implications for middle ear affection. In: Widemar L, ed. Membrana Shrapnelli and its Mast Cells. 1985:1-11.
37. Rakover Y, Shneyour A, Rosen G, et al. Comparison of the proteins of middle ear effusion with human mast cell proteins. J Laryngol Otol 1995;109:1146-50.
38. Lim DJ. Structure and function of the tympanic membrane: a review [Review]. ACM Otorhinolaryngol Belg 1995:49:101-15.
39. Nilsson G, Butterfield JH, Nilsson K, et al. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994;153: 3717-22.
40. Mattoli S, Ackerman V, Vmori E, et al. Mast cell chemotactic activity of RANTES. Biocliem Biophys Res Commun 1995;209: 316-21.
41. Taub DD, Proost P, Murphy WJ, et al. Monocyte chemotactic protein1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clinlm-est 1995 ;95:1370-8.
42. Dalian S, Cavani A, Bergamini G, et al. Integrin expression in middle ear cholesteatoma. A eta Otolaryngol 1994; 114:188-92.
43. Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Sludy.Acta Otolaryngol 1994;114:295-302.
44. Shinoda H, Huang C. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death. Laryngoscope 1995; 105: 1232-7.
45. Bujia J, Kim C, Holly A, et al. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 1996;17:203-6.
46. Welker P, Grabbe J, Czarnetzki BM. Human keratinocytes release mast cell differentiation factors other than stem cell factor. lut Arch Allergy Imtmmol 1995;107:139H.
47. Saarinen J, Kalkkinen N, Welgus HG, et al. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Cliem 1994;269: 18134)0.
48. Gruber BL, Marchese MJ, Susuki K, et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989;84:1657-62.
49. Pansier SC, Agresti CJ, Schwanz GK, et al. Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype. Am JO/o/1993:14:126-30.
50. Vennix PP, Kuijpers W, Tonnaer EL, et al. Cytokeratins in induced epidermoid formations and cholesteatoma lesions. Arch Otolaryngol Head Neck Surg 1990; 116:560-5.
51. Broekaert D, Coucke P, Leperque S, et al. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Khinol Laryngol 1992;101: 931-8.
52. Bujia J, Schilling V, Holly A, et al. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol 1993;! 13:364-8.
53. Sasaki H, Huang CC. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Siirg 1994;! 10: 310-7.
54. Brown JK, Jones ÇA, Tyler CL, et al. Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest 1995;107:95S-6S.
55. Walsh LJ, Trinchieri G, Waldorf HA, et al. Human dermal mast cells contain and release tumor necrosis factor-a, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 1991;88:4220-4.
56. Yan SD, Huang CC. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Ann Otol Rliinol Laryngol 1991:100:157-61.
57. Yan SD, Huang CC. The role of tumor necrosis factor-alpha in bone résorption of cholesteatoma. Am J Otolaryngol 1991;12:83-9.
58. Bujia J, Holly A, Kim C, et al. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation] [German]. Laryngorhinootologie 1993:72:279-83.